Co-Chairs: Jeffrey R. Strawn, MD, and Jean A. Frazier, MD 

AACAP’s 2023 Pediatric Psychopharmacology Update Institute addresses how clinicians can conceptualize and manage aggression and other symptoms in various child and adolescent psychiatric disorders. The presentations focus on a shift from treating disorders to understanding and treating symptoms, including aggression, across disorders. The Institute also highlights recent updates and developments in the child and adolescent psychopharmacology literature. Finally, attendees are able to participate in small-group case discussions about how the evidence-based information can be tailored and applied to individual patients with complex presentations. 

Here’s What’s Included

• In-person meeting with time to network and interact with participants
• Ten (10) presentations from top experts
• Opportunity to participate in two (2) small-group consultations with our master clinicians
• Chance to ask questions during three (3) Q&A panel discussions
• Ability to earn up to 11 CME credits

Meeting Objectives

At the conclusion of this meeting, attendees will be able to:

1. Describe how psychopharmacologic treatments can be chosen to target impulsive aggression across disorders.
2. Describe pharmacologic approaches to individualize psychotropic medication selection and dose in children and adolescents.
3. Stratify interventions based on comparative efficacy and tolerability data.